drugset

drugset / Trial / NCT00035269

New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)

NCT00035269 ↗

Phase 3 Completed 230 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study will treat patients who have a community-acquired pneumonia that is due to a specific bacteria (S. pneumoniae)

Timeline

Start: 2001-12
Primary completion: —
Completion: 2003-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Linezolid	Other / unclassified	—	—

Indications